[1] Late Presentation With HIV in Africa: Phenotypes, Risk, and Risk Stratification in the REALITY Trial

[2] Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons. A double-blind, placebo-controlled trial